Bioventus Inc. (NASDAQ: BVS) reported Q1 EPS of ($0.26), $0.11 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $119.06 million versus the consensus estimate of $116.58 million.

For earnings history and earnings-related data on Bioventus Inc. (BVS) click here.